Pharma Focus Asia
KP - Sustainable Packaging Solutions

Rentschler Biopharma to Open New Biopharma Manufacturing Facility in Massachusetts, USA


Rentschler Biopharma plans for the new biopharma manufacturing centre (RBMC) facility at its manufacturing site in Massachusetts, USA.


The new, state-of-the-art RBMC introduces an additional 22,000 square feet of manufacturing cleanroom space and accommodates four new 2,000 L single-use bioreactors. 

The existing site has transitioned from a single-product commercial facility to producing multiple products using an intricate bioreactor setup of up to 500 L capacity.

This expansion marks the largest in over 150 years and will effectively double Rentschler biopharma's global cGMP capacity. The facility will primarily concentrate on the commercial production of highly complex molecules for international markets.

The RBMC facility is designed for easy adaptability, aligning with evolving requirements, in expanding international capabilities to delivering comprehensive development and production solutions for the biopharmaceutical sector.

The biopharma manufacturing facility is scheduled to be operational in the second half of 2024.

Name    Rentschler Biopharma
Type      New Construction
Year       2024

Latest Issue
Get instant
access to our latest e-book
MFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Gibco Adherent Kidney Media PanelCPHI Korea 2024Equinix accelerated medical research...CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?